drugset / Trial / NCT05100134
Managed Access Programs for LDK378, Ceritinib
Summary
The purpose of this registration is to list Managed Access Programs (MAPs) related to LDK378, Ceritinib.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Ceritinib | Small molecule | — | Oral |